Suneva Medical is a privately‐held regenerative aesthetics company focused on and dedicated to developing, manufacturing and commercializing novel, differentiated products for the aesthetic markets. The innovative aesthetics industry leader markets flagship brand Bellafill®, the only dermal filler on the market with five-year safety and efficacy data from the largest and longest prospective dermal filler study ever conducted by the FDA. Bellafill® is approved for the correction of nasolabial folds and facial acne scars. The company markets Bellafill® in the U.S., Canada, Hong Kong, Korea and Mexico. Meeting the call of physicians and patients growing demand for clinically-proven and less invasive solutions, Suneva Medical added a cutting-edge PRP technology that features an innovative high platelet capture design and Puregraft, the world's the most predictable fat graft in the market, to their portfolio in 2019. For more information, visit www.sunevamedical.com.